Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Xijing Hospital |
---|---|
Information provided by: | Xijing Hospital |
ClinicalTrials.gov Identifier: | NCT00663988 |
Progress in composite tissue allotransplantation provides a new remedy for severely disfigured patients. We plan to carry out allograft composite tissue transplantation after a careful systemic preparation.
Condition | Intervention | Phase |
---|---|---|
Pharmaceutical Preparations |
Procedure: human transplantation |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Human Partial Facial Allotransplantation |
Enrollment: | 1 |
Study Start Date: | April 2006 |
Primary Completion Date: | April 2006 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
III: Experimental
The effect of human partial facial allotransplantation
|
Procedure: human transplantation
Allograft composite tissue transplantation. procedure. medication
|
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
normal function of heart/liver/kidney
Exclusion Criteria:
abnormal function of heart/liver/kidney
Responsible Party: | Xijing Hospital ( Guo Shuzhong ) |
Study ID Numbers: | XJ-GuoSZ0709 |
Study First Received: | April 20, 2008 |
Last Updated: | April 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00663988 |
Health Authority: | China: State Food and Drug Administration |
face transplantation |
Facies |